NeoGenomics to Participate in the 20th Annual Needham Virtual Healthcare Conference
Press Release
Read More
Molecular Residual Disease detection in early stage breast cancer with a personalized sequencing approach
Literature
Read More
Personalized circulating tumor DNA analysis in head and neck squamous cell carcinoma: preliminary results of the Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS) study
Literature
Read More
Resistance mechanisms to BRAF inhibition identified by single circulating tumor cell and cell-free tumor DNA molecular profiling in BRAF-mutant non-small-cell lung cancer
Literature
Read More
NeoGenomics Schedules its First Quarter 2021 Earnings Release for May 5, 2021
Press Release
Read More
Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC)
Literature
Read More